Human Researchze: 18pt;">Despite its immense popularity, clinical research on milk thistle’s liver benefits remains inconclusive.
Milk thistle (silymarin) is a flowering herb most commonly used to help with liver disorders. Milk thistle has been suggested to support liver health by:
- Liver regeneration. Silymarin appears to promote liver tissue regeneration.
- Stabilizing cell membranes. Silymarin can protect liver cells against toxins by altering and stabilizng their membranes.
- Antioxidant activity. Silymarin protects the liver from oxidative stress by neutralizing free radicals and increasing the body’s own antioxidants.
- Protecting against fibrosis. Silymarin prevents specialized cells from depositing fibers that lead to fibrosis and cirrhosis.
- Reducing inflammation. Silymarin has anti-inflammatory effects that protect the liver from damage.
Milk thistle (Silybum marianum) is a flowering plant native to the Mediterranean. It has been used for over 2,000 years for a variety of conditions, but is best known for its liver-protective effects. The main active ingredient responsible for milk thistle’s benefits is called silymarin.
Today, milk thistle products are used to lower blood cholesterol, help with diabetes, allergies, heartburn, and acne, and support liver and gallbladder health. Common liver conditions people take milk thistle for include cirrhosis, hepatitis, and non alcoholic fatty liver disease (NAFLD).
Despite its reputation as the number one herbal remedy for liver health, four decades of clinical research on milk thistle have reported mixed results, with some positive findings, and some studies showing no beneficial effects.
How Milk Thistle Might Help With Liver Health
Milk thistle contains multiple flavonoid and polyphenol compounds – including silybin, silydianin, and andsilychrstine – collectively known as silymarin. Silymarin has been suggested to protect and support liver health through five major properties: 1
Promoting liver regeneration
Because silymarin has a similar structure to steroid hormones, it appears to be able to promote the production of DNA and RNA. In turn, this effect stimulates liver tissue regeneration. 2
Supporting liver cell membranes
Oxidative stress caused by free radicals is known to play a critical role in many serious health disorders, including liver conditions.4 Silymarin helps neutralize free radicals, and also increases the levels of glutathione, one of the body’s main antioxidants.
Protecting against liver fibrosis
When hepatic stellate cells transform into activated myofibroblasts they deposit collagen fibres in the liver, leading to fibrosis and eventually cirrhosis. Silymarin has been demonstrated to suppress this transformation. 5<
Reducing liver inflammation
Milk Thistle Uses & Benefits for Liver Health
Milk thistle is the most popular herbal supplement for supporting liver health and protecting against hepatitis, cirrhosis, and fatty liver disease – the most common liver disorders.
Despite its popularity, decades of clinical research on milk thistle’s liver-protective effects have produced inconclusive, mixed results, with some positive and some negative findings.
Systematic reviews of this available research – which includes dozens of studies – have come to similarly contradictory conclusions. Whereas one recent review concluded that, “Our results question the beneficial effects of milk thistle for patients with alcoholic and/or hepatitis B or C virus liver diseases and highlight the lack of high-quality evidence,” 7 another review stated that, “…it is reasonable to employ silymarin as a supportive element in the therapy of Amanita phalloides poisoning but also (alcoholic and grade Child ‘A’) liver cirrhosis.” 8
As such, it seems that milk thistle and silymarin are worth a try for people suffering from liver health problems, but efficacy is not guaranteed.
In addition, many milk thistle supplements are advertised as a way to “cleanse” or “detoxify” the liver, but these terms are simply marketing buzzwords without any medical backing. The only appropriate medical usage of the term “detox” refers to the treatment of people with drug addiction.
Human studies of silymarin report conflicting results, with some studies reporting positive findings in people with hepatitis C, NAFLD, cirrhosis, and alcoholic liver disease, and other studies showing no beneficial effects.
This randomized, double-blind, placebo-controlled study looked at the effects of silymarin on liver disease in people with chronic hepatitis C who did not respond to standard (interferon) therapy. A total of 154 people were given placebo, 420 mg, or 700 mg silymarin 3 times daily for 24 weeks. There was no significant difference in ALT levels – a measure of liver function – or other measures of liver health between the three groups.
- The researchers concluded that “Higher than customary doses of silymarin did not significantly reduce serum ALT levels more than placebo…” 9
This National Institutes of Health-sponsored study explored the effects of silymarin on chronic hepatitis C patients who didn’t respond to antiviral therapy. A total of 1145 patients were questioned on their supplement use. Those who took silymarin were found to have fewer and milder symptoms of liver disease and better quality of life, although these improvements were not associated with a change in viral activity or inflammation.
- The researchers concluded that “Silymarin use among patients with advanced hepatitis C-related liver disease is associated with reduced progression from fibrosis to cirrhosis, but has no impact on clinical outcomes.” 10
This widely-cited randomized, double-blind, placebo-controlled study tested the effects of silymarin on liver cirrhosis. A total of 170 patients were given placebo or 420 mg silymarin daily for 2 years. The silymarin group had a higher 4-year survival rate (58% vs 39% for placebo), and further analysis revealed that the treatment was effective for patients with either alcoholic or Child A-type cirrhosis.
- The researchers concluded that “The effects of silymarin appears to be in the prevention of some metabolic or toxic effects of alcohol on the liver.” 11
This randomized, double-blind, placebo-controlled study examined the effects of silymarin on liver cirrhosis. A total of 125 people with alcoholic liver cirrhosis were given placebo or 450 mg silymarin (in three doses) daily for 2 years. Silymarin did not show any significant effects on the progression of the condition.
- The researchers concluded that “The results of this study indicate that silymarin has no effect on survival and the clinical course in alcoholics with liver cirrhosis.” 12
This randomized, placebo-controlled study examined the effects of silymarin on non alcoholic fatty liver disease (NAFLD). A total of 64 patients were given placebo or silymarin (210 mg) daily for 8 weeks and advised to follow a diet and exercise regimen. Compared to placebo, the silymarin group experienced a significant reduction in ALT and AST enzyme levels – the leading markers of liver health.
- The researchers concluded that “silymarin is a useful herbal drug for the treatment of NASH.” 13
In this randomized, double-blind, placebo-controlled study, 99 non alcoholic fatty liver disease (NAFLD) patients were given placebo or silymarin (700 mg) in three daily doses for 48 weeks. Although the silymarin group experienced better improvements in some measures of liver health such as fibrosis, it did not have a significant effect on NAFLD activity score (NAS).
- The researchers concluded that “silymarin (700 mg, given 3 times daily for 48 weeks) did not reduce NAS scores by 30% or more in a significantly larger proportion of patients with NASH than placebo.” 14
Milk thistle silymarin is worth a try for liver issues. Despite its reputation as the go-to liver herb, extensive research on milk thistle has reported mixed results. As such, we can’t say for sure whether it will work for you, but it’s worth trying.
Successful studies tend to use doses containing 210-420 mg silymarin. Most milk thistle extracts come in 250 mg capsules containing 80% silymarin. As such, taking 1-2 capsules translates into dosages similar to the ones used in clinical research.
- Claus Hellerbrand et al. The potential of silymarin for the treatment of hepatic disorders. Clinical Phytoscience January 2017, 2:7. ↩
- Machicao F, Sonnenbichler J. Mechanism of the stimulation of RNA synthesis in rat liver nuclei by silybin. Hoppe Seylers Z Physiol Chem. 1977 Feb;358(2):141-7. ↩
- Basiglio CL et al. Differential effects of silymarin and its active component silibinin on plasma membrane stability and hepatocellular lysis. Chem Biol Interact. 2009 May 15;179(2-3):297-303. ↩
- Halina Cichoż-Lach and Agata Michalak. Oxidative stress as a crucial factor in liver diseases. World J Gastroenterol. 2014 Jul 7; 20(25): 8082–8091. ↩
- Clichici S et al. Silymarin inhibits the progression of fibrosis in the early stages of liver injury in CCl₄-treated rats. J Med Food. 2015 Mar;18(3):290-8. ↩
- Kim M et al. Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: analysis of isolated hepatic stellate cells. Int J Mol Med. 2012 Sep;30(3):473-9. ↩
- Rambaldi A et al. Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD003620. ↩
- Saller R et al. An updated systematic review with meta-analysis for the clinical evidence of silymarin. Forsch Komplementmed. 2008 Feb;15(1):9-20. ↩
- Fried MW et al. Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial. JAMA. 2012 Jul 18;308(3):274-82. ↩
- Seeff LB et al. Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial. Hepatology. 2008 Feb;47(2):605-12. ↩
- Ferenci P et al. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol. 1989 Jul;9(1):105-13. ↩
- Parés et al. Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial. J Hepatol. 1998 Apr;28(4):615-21. ↩
- Hassan Solhi et al. Silymarin in treatment of non-alcoholic steatohepatitis: A randomized clinical trial. Caspian J Intern Med. 2014 Winter; 5(1): 9–12. ↩
- Wah Kheong C et al. A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis. Clin Gastroenterol Hepatol. 2017 Dec;15(12):1940-1949.e8. ↩